Neutralization of vascular endothelial growth factor (VEGF) reduces tumor neovascularization and drugs that neutralize VEGF activity have increased the survival for patients suffering from certain cancers (Apte et al,2019). This evidence concerns the gene VEGFA and neoplasm.